! " # $
-1
-2 3
: .
" #
$
"
% &'
$ -
)
* #+, - .
* / 01 2
- 3)
4 5 . 2 6 7 8 9 : /
$
; 0<=
; 4 -
) )4' 2 9 "
>5 . 9 : :
8
$ >2 24 A
;5B 5 C5 8. 2 D ;E 8 F G
±5 30
$ J K2
5 .
8)3 8 * 8 * 5 7 8
9 )
# L<M 5 85
mg/kg
40 )5 4.
* M 8
Intra-peritoneally (IP)
2 N &
7 ) O'
$ 8 P
N &2 ) )4' C 8 2 9
Q 8
J C
- $
&
* M 8 "R 9
&2 IP
P 8 $ 7 ) O' N
N &2 ) )4' C 8 2 9
.
;E $ ; S)
T
; , $
; $
; U
VW= 6
" 5 .
3) 5
&-
" B B SPSS
L: $t
4
"
05 /
P 0 4)- = 0 WY2 8 &>2 .
) :
2 9 2 9
+ (
4 +)1
5 8 ; , S) "
; T S) 8
) 001 /
P<0 (
; U $
) 001 /
P<0 (
VW= 6 2
) 05 /
P<0 ( +)1
4 B 8 "
. )
) )4' ) )4'
+ (
4 +)1 S) ;E
8 "
B ) 05 /
P<0 .(
]5 :
8)- )- 8 9 : "
J 2 B 8
3) 34 <^ * / 8 ) 5 5
= ) < " 5 8_ 2 0 # ` 2 ; " -
8< Y " )U .
Q ; :
Q 2 9 Q )4' ) ) )4' 2 ( Q
" F
) 14 ! 4
!
" #$ % & ' 1386 (
,- . : 13 / 3 / 1386 . 1 234
: 30 / 8 / 1386 6 .7
: 27 / 9 / 1386
a 4 5
) Q
&= % &' W# CU5 $ % &' %U5 $ 2 7 B
G B :
&=
-
&= % &' W# CU5 -
% &' %U5 -
2 7 B Dc
3W2 : 3336001 - 0281 5 : 3324970 - 0281
% 5 )%9 '
[email protected] : [email protected]
W# *h i# 2
&= % &' W# CU5 $ % &' %U5 $"R 9 . - B
" < 8) " >U5 3
! "!
jV,
&5 D ' ;5 = 2
0W 8)1 4 W#
>2 B 5 * / * </ 8 8
) 2$1
.( K = B 4. 2
" 8. M c
44.
$ C5 " B k _ .
B
%
&5 ' 7 W
35 $
" &
_
% &'
$
"
3) 44.
Q T 6 8.
5 l : 1 P &' 4
) 3 (.
B N<, 1999
a 8
FDA*
$ D 25
% B
" %
3)
n4' 7 44.
W
" o
K2 $ -
K2 D . $ 5 _ " = 8]- 7
& "
84 5 4 ) 4 (.
Charles Mcleskey
1999
5 F &
8.
979 8. "
)
Scott and White
8)- = 7 _ 0 # 5
$ 170
" ;5B 35 5
5 2
55 %
" T 5 P 45
%
" T 5 8
. 3) 5
) 5
Murph (.
<W: 8 & 5 8 U
5 )
6 .(
_ B
" p 1 8.
P &' U - $ qcU
3) 44.
) 7 (.
rs 4 E 4# 8 8. 5 8W _
B
3) 8.
5 * / 8 8_ 2 "
8.
B 8
. ' V_
) W. D . 1 E B
8.
M 1
W_
<W= *+%U ` # t42 "
a / Q
4u ' V_
1 U- B .
.+' 4< E W_
"
4.
. v %
G
i "
.
J) 8. 5
3) $ w 6 E # -
8>9
)5B +1 4 ;)5 3#
2 P x
85
*U.S. Food and Drug Administration
K2 V_ )7 5 <5 _ y # 5
&
.
5 " 4 %Y) 1 4= D . V_
.
v % ;42 85 _ "
O342 C) 8W K
$ 4.
8%W
z c {#
5
&
) 4 - 11 .(
)U
_ W# 8 .| p 1
< . 2 9B 5 8
8.
P V . 2 2
B
» 84
« ) .
8) 8. )=
"
.
5 9B $
8 B _
9B 5 8 " C
<2 0 .
9B
8 8. 9 -
•
B 5 p 1 " )
Uc .
; 0<= 8. 5 " 8 9 : . 3) 5
$
)U y # 8
' ; "
) 13$12 .(
$ 5 ) 7 _ Dc
8 _
3) 1 rs J R 44.
$ 5 . 43
%
5 . 3)
.
h
j _ 01 2 P 8. {# 89
€ 5 :1 "
7 _ 7 - "
5 • T = 8 )
14 .(
; " 01 2 C 8 9 : P
8)- = 4 E )4
5 "
U 01 2
Q 0
$n4U2 $ . 2 $8 W. " ; $T ;2 $ 5B $ % "
‚ )7 .
) 15 .(
8 8_ 2 8.
s "
" $ _ 01 2
s J
01 2 5 2 i * /
8) _
. )4'
" 8W _ 2 9 )
B V_ 8. 4) ;
) U- D . <W= "
1 8. 5
5
&
DM 1 8 8_ 2 5 2
U2 * / 4.
. 8 ]5
85 1 8.
3) P &' 8 8 _
$ = # <W= " 8. 45 ) 4 5 € 5 :1 01 2 C " " ; "
>
. D &- y # 8. " Y5 8 4 Q
VW= c) ; c) o 4u
- 8. 5 5 w= 01 2 8 ` #
. 5
$ 2 8 & >2 h
5 4 1
.
* # 6 {#
8.
5 U •' P
$
* /
= 0<
= ) )4' 2 9 ;
.
# " $ %&'
$ >2 8 9 :
O' 8 ;2 2
1
$ B PU1
B 5 ' 0% 8 . v
8.
* M 8 8W . C) ƒ 2
# "
:
30
8W . C)
350cc
:K vB
5 C) ƒ 2 8. &
5
&
8)- B "
$
* 8 3)
6
$ 9 ) #
"
30°c
) _ &_ 8 &>2 " W_ ]4 8
(
#
"
Q
„ WS2 ;_ # O•
= 2 %5 C) .
, ]Ws 4E 07
K . 07
cU J>7 # 4
;2 q9 1 vB 8
)
"
10
$ 20
$ 30 40 (.
F 8
); cU "
mg/kg) 40 ( v c)5 .
J>7 2 9
& 5 v c)5 " ,
F 8.
5 9 5 F ;
5 .
cc K 5
8)- ]5 F "
.
* 5 7 8 9 :
24 A 3 5 " F G
C5 4 <9B •5 5
±5 30 8. 5
a 8
KY2
;2 … . k= ) ' 2 K 5 8
. F
* M 8
D ;E
2 O3=
= 2 "&W- "
ƒ
Y
v W: 2 7 :
°c) 25 - 20 ( vB rs 8. 9 7
4) - .
$ 7
&= % &' W# CU5 85 c5
5 " ;C5 .
8)3 8 * 8 * 5 7 8
# L<M 5 85
mg/kg
40
* M 8
Intra Peritoan (IP)
N &2 7 ) O'
8 P
) )4' C 8 2 9
& >2 .
8
J C
- $
&
8 "R 9
IP * M
&2 P 8 $ 7 ) O' N
) )4' C 8 2 9
& >2 .
K
) )4'
mg/kg
100 8)- ]5 * M 8
IP
&2 N .
* M 8 J 2 9 K
]5
8)- :
* U B
$ 2 K
2 9 K
15cc
]5
8 8_ 2 8)-
8 $ K
5 cc
D . .
K 8<4' "
8 "
50
8)c F
8< _ P2 8 P2 * M 8
"
cm³ 8 10
× 10
× 5 8]3Y " o 8.
"
$
=
8) r B 2 9 8 8)UsB 8<4' .
;
8)- ]5 * M 8 8W7 8 0 :
1 - 8W7 B 85 U5 8. "
O342 ]5
) O342 +)1 (.
2 - O342 B ' 8. % Y2 8W7
J]4 .
3 - 7 _ NKY B 8. 7 _ 8W7
T 4.
. D •'
;E S)
j
4)- = ]5 :
w9 - T
(Induction) ; :
5 ) 8K = (
, 8.
U.
2
F ; F
. ) 9 8. 5
8W7
sB ; 07
% 5 % * . 7
w= ) 7
.(
v - ,
(Duration) ; :
5 ) 8K = ( 8.
; F
= 5
. )
$ 07 8. 5 *
B ' 8)- * M 7 ;
. 7 8 T 7
5 .(
… - U
(Recovery) ; :
5 ) 8K = ( 8.
0 . " 8 F
. )
; U
; 0<= 6 8 7
07 2
' 8 ;
.(
-
VW= 6
(Heart Rate)
:
F VW= 6 2
8K = P )
2 7 VW= " UC5 =
6 $ l 6 0 9 8 8. 4E 2 6
F 0 = & 5 JUE N , .(
"
k _ 3) $ " B 5
&-
SPSS
" B B 4 L: t
"
05 /
P 0 8 &>2
0 WY2
4)- =
.
( )
;E S)
$
"
85 5 2
) F ( 5 $ 5 </ "
.
* C5
;
1 ) 2 9 +
"R 9 & - (
2
) 2 9 + ( V 2 2 8 33
/ 74 33 / 49 8K = 8 B Q
+)1 ]5
4 " B
$ C * <# 8 Q *
;
2 ) . 1
) _ 1 (.
; * C5
3 )
) )4'
+
"R 9 & - (
4 )
) )4'
+ ( V 2 2 8 83
/ 91
83 / 33 8K = 8 B
& 5 +)1 Q ]5
" B
4 C * <# 8 Q
; *
4
) . 3
) _ 2 (.
* +
0‡ 8 $8 9 : B 8 n )5
8_ 2 ) < " " . 8 C4 ;
.
D . J R Y2 " ; VW= 6
8.
2 C UE 2 9 3) C4 D .
.
:1 2 9 ; " " %
_ 4 Q
0 2
&
p 1
&9 Q
K9 4u
"
)U 1 / $ ;
5 # 2 9
Q O% 9
; ,
"
5o , 8. )U ) )4' K &2 <
,
;
8) " 34 " '
0 2 $
&
' * 6
4.
.
; U
) )4' 8 < 5 2 9 "
2 Y2 " ; h
5o , /
2 8.
T 6
)U =
&
2 9 -
<W, .
"
N = P W 1 4 J 7 = U4) <
5 1
) 16
$ 17 ( 4 Q 0<= 3) J 7
)U B 5 * :1 )% ;
4.
. F &
5 V< # 8.
5 . J W. 5 "
Ca++) ( )
18 ( Q - ,
5 . %W # +)1 {# < "
5 "
5 5 . D . {# W
"
W.
5 ) 16 (.
! 1 -
$ % &' ( % ) * $+ , - . 1
2
* 1
) 1 )' + 3 4 ( 2
) 1 )' + 4 ( 6 & 7(4
%
T
; ) 8K = ( 31
/
±5 33 / 74 93
/
±3 33 / 49 001
/ P<0
; ,
) 8K = ( 19
/
±10 84 06
/
±19 33 / 103 05
/ P>0
; U
) 8K = ( 35
/
±4 17 / 88 18
/
±3 83 / 68 001
/ P<0
VW= 6
) 2 ( 39
/
±19 144 11
/
±11 67 / 115 05
/ P<0
! 2 -
% &' ( % ) * $+ , - .
$ 1 2
* 3
) 9 9) : +
3 4 ( 4 ) 9 9) : +
4 ( 6 & 7(4
%
; T ) 8K = ( 92
/
±27 83 / 91 57
/
±10 83 / 33 01
/ P<0
; ,
) 8K = ( 14
/
±19 83 / 90 34
/
±72 5 / 280 01
/ P<0
; U
) 8K = ( 33
/
±19 17 / 137 72
/
±84 25 / 461 01
/ P<0
VW= 6
) 2 ( 22
/
±26 33 / 161 22
/
±26 17 / 123 05
/ P<0
V< # 8. W 8 9 : P
]5 D .
6 VW=
) 19 ( 4 Q
8 0<= #
8_ 2 0 = /h2 2 9 " .
VW= 6
8) rC5 .
)<^ DK5
K9 5 .
> = U4) " < 2 9 J 5 %
Us 2 S2
"
9 W Q
" , 8 5 *o <2 8.
Na+ K+
ˆ <= )
Ca++
Us
"
5 " W_ W
5 * M Us <, %W # Q
B W#
2 Us " • 9 8 o +Y5 ‰&_ 8
4 Š2 ' 8 o P - .
8 8_ 2 4 -
` -
$
)U K &2 " < 8 < 5 = U4) < "
/ ` # VW=
5 r . D . V<
VW= 6
" % 5
o 4
U5 v 7
$
VW= {#
5 Q
{# 4u
1 U- - ` # " U 5
.
8 1 U- -
5 . 8. W W#
J J W. 5 "
8.
5 . 5 {# < 45 J
"
J W. J
4 Q
{# 3)
2 8.
h K2 2 9 /
% R 4 / P
8) . T >
8. ;‹ 4E 2
2 9 J 5 % 8. 2 ]5 8 8_ 2
;4U ' = U4) " <
8. " %W #
5 .
2 9 )U 1 * / $ 5 "
# 5
Q
J 5 % 8. p c
) )4'
* )
N = , 8
8)1 4 5
. 4 - 8)
J) < "
(GABA ergic) P R
r / .
* ) 5 1 8 ) )4'
NW 2
0M 7 O%W• . K2 V< 8.
5 . W. "
(Cl-)
5 8 " 4 B 4 B
2 P
(GABA) GABA .
)• "
GABAA
GABAB
.
* ) O%W• .
GABAA
Cl-
U2 4 5
.
&S ` - 84 B )• "
GABAA
W. 5 . 8 2 8) U5
> ;
4.
.
$ 4 -
. 8 v :6 D . v 1 *o+)1
5 ) 17$16 (.
5 /h2 4< &
"
U5 U
.
5 - ; 0<= 8. ;
5
$
K9
"
- * M ) ;
.
5o , ;
2
*
) . VW= 6 )U ; U
4 8_ 2 0 = * S2
)U )
01 /
P<0 ( 4 Q
5 5 8 9 : J 2
3) 34 <^ * / 8 )
5 8_ 2 0 # ` 2 ; " - " )U = ) < " "& >2
8< Y .
<W= * / P -
*+1 2 = #
= 8 9 : 4 E )4 ; "
8)- .
V_ - 4 E
1 " U- ' $
G ). 35 <W= $ % $" % . 2 ) 20 ( Q
& 5 6 7 8 9 : ˆ < K2
0<= n )5
; "
4u Q U
‚
& 5 * 5 7 J
ˆo )7 8.
<W= *o+)1 5
. , - 8 8_ 2
" 85 1 8.
D &- 8
$ .|
8. " 6 8)%5
<) " rC 5 "
$
ƒWs 4
$ 9B
-B D.
" V . 2 )7 C4 * &W-
" = "
' 45 /o
$ {#
c) &S w i2 45 1 y # 8.
$
J) 1 " U- '
F & i VW= J]4 5
8 8_ 2
o VWs " 8.
5
$
<_ y # %
" r' 5
4.
Q
" " 45 C "
8.
4 8) 0 K) / J 45 2
$
& 5
01 2 W# 8 <5 _ y # " %
4 8) J 4E / .
3) * i %
8 0 2 8. 85 B 5
5 v 4)_ P &' 8 8 _ VWs 5 1
j _ *o+)1 q cU2
"
N 2 8 r' 5
.
" W# 85 B
$ 3 5 2 a
/
Q
* 5 % < . 8. 8 2 7 0W • ) ; ,
" 8 € 5 ) o =
$
4;_ ) N, 4 p c
$
&‡ 7
) 22$21$18 .(
.+ /!
:
1 - 7 l . .
W_
. • E .
;2 : + t4 - U5 )- Q
1375 .
2 - T "
. .
W_
.
;2 :
;2 CU5 Q
1376 .
3- McLeskey C, Meyer TA, Baisden CE. The incidence of herbal and selected neutraceutical use in patients. Lancet.
1999; 354: 136-37.
4- A.S.A. What you should know about your patients use of Herbal Medicines. Available From:
http:/asahq.org/Proflonofo/ b/herbbro.html. 1999.
5- McLesky C. Researchers warn of potential herbal- anesthesia interactions. Available From:
www.chfpatients.com/stew/herbs.htm
6- Murph JM. Preoperative considerations with herbal medicines. AORNJ. 1999; 69 (1): 173-75.
7 - l " 3 _
$
;
"
$ G "
.
" U
. 8 4 . 1382 Q 25 ) 1 :(
21 - 22 .
8 - T " 5 1B _ 7
$ Ž W .
" . " 4 .
;2 : + B CU5 W# * U)5 &.
. 1381 .
9 - l " 3 _
$ 5 9+_
$
= s . / 5 W.
3 2+5 9 "
.
&= % &' W# CU5 W# 8W>
. 1382 Q 25 : 8 - 12 .
10- Schachieter M. Mecanism of microbial disease. USA: Williams & Wilkins; 1989.
11 -
" 3 _ l
$ . 5
$
= s
$
" ; . /
3 2+5 9 9B " ; 1 * 7 8_
/ CU B
5
" ). B 44.
. U5 8W>
CU5 .
1381 Q 40 : 17 - 22 .
12- Sabar R, Kaye AD. Pre-anesthetic assessment of a patient taking herbal medicines (Part I). Anesthesiology News.
2000; 26 (2): 32-38.
13- Sabar R, Kaye AD. Pre-anesthetic assessment of a patient taking herbal medicines (Part II). Anesthesiology News.
2000; 26 (3): 40-44.
14- Kaye AD, Clarke RC, Sabar R, Vig S, Dhawan KP, Hofbauer R, Kaye AM. Herbal medicines: current trends in anesthesiology practice- a hospital survey. J Clin Anesthesia. 2000; 12 (6): 468-71.
15- Kam PCA, Liew S. Traditional Chinese herbal medicine and anesthesia. Anesthesia. 2002; 57: 1083-1089.
16- Katzong, B. Basic and clinical pharmacology. Vol: 1. St.Louis: Mosby; 2003.
17- Goodman & Gillman. The pharmacological basic of therapeutics. Vol: 1. 12th ed. St.Louis: Mosby; 2004.
18- Leader F, Hoffman FA. Pharmaceutical News. 1996, 3: 19-25.
19 - l " 3 _
$
l 5 ;_
$
<#
$
" ;
$ G "
.
* /
B #
(Allium Sativum L.)
89 & & W 6 6 <K5 * =
9 5 B D &- ' 5 YM F .
8 4W - W#
- * K KY2 U •' :
. 1385 Q 22 ) 1 :(
42 - 46 .
20- Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplemants containing ephedra alkaloids. New England J Med. 2000; 343: 1833-38.
21- Borins M. The dangerous of using herbs. Postgraduate Med. 1998; 140: 91-99.
22- WHO. Regulatory situation of herbal medicine. A World Wide Rev. 1998.
Title: Effect of using garlic before anesthesia on the process of anesthesia with Halothane and Thiopental in male mice
Authors: H. Jahani Hashemi1, H. Jafari2, S. Kazemi3 Abstract
Background and Aim: Nowadays using herbal medicine is common among people. A large number of patients who take pharmaceuticals also use herbal medicine without knowing anything about the interaction between them. The present study was carried out to determine the effect of consuming garlic before anesthesia on the process of anesthesia with Halothane and Thiopental in male mice.
Materials and Methods: In this study 24 mice with the average weight of 30±5 gr were divided into 4 groups (6 in each). Two groups of the animals received 40mg/kg of garlic concentrate intraperitoneally in the morning and in the afternoon for three successive weeks and after a two days' rest one of the groups were injected with halothane and the other one received pentobarbital. Simultaneously, the remaining two groups were injected with physiologic saline intraperitoneally and under the same condition. After anesthesia, four variables namely induction (A), duration (B), recovery (C) and heart rate (D) were assessed. The obtained data was analysed by means of SPSS software (12.0) and statistical t-test; and P 0.05 was taken as the significant level.
Results: In the former 2 groups which had been injected with "Halothane" and "Halothane+garlic" there was a significant difference in the variables A (P<0.001), C (P<0.001) and D (P<0.05). In the latter 2 groups injected with "Pentobarbital" and "Pentobarbital + garlic" there was a significant difference in all the four variables (P<0.05).
Conclusion: Regarding the findings of this study and applying them to humans, positive and negative effects of simultaneous use of garlic together with anesthetic drugs must be taken into account. Thus, the dose of the drugs must be determined more accurately.
Key Words: Anesthesia; Mice; Garlic; Halothane; Thiopental (Pentobarbital)
1Corresponding author, Assistant Professor, Faculty of Medicine, Qazvin University of Medical Sciences. Qazvin, Iran [email protected]
2Instructor, Department of Pharmacology, Faculty of Medicine, Qazvin University of Medical Sciences. Qazvin, Iran
3Student of Anesthesia, Qazvin University of Medical Sciences. Qazvin, Iran
